PHARMACEUTICAL PRODUCT DEVELOPMENT INC 4
4 · PHARMACEUTICAL PRODUCT DEVELOPMENT INC · Filed Dec 6, 2011
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Disposition to Issuer
Common Stock
2011-12-05$33.25/sh−1,139$37,872→ 0 total - Disposition to Issuer
Stock Options (to buy)
2011-12-05−9,095→ 0 totalExercise: $28.52→ Common Stock (9,095 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Pharmaceutical Prodcut Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc. dated as of October 2, 2011, on the effective date of the merger contemplated by the Agreement (the "Merger"), each of these shares of common stock was automatically converted into the right to receive $33.25.
- [F2]These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes.